Table 4.
CDI studies in eyes with PXG.
| PXG vs. Control Groups | PXG vs. POAG | |
|---|---|---|
| Kocaturk et al., 2021 [59] | • ↑RI in OA, CRA | - |
| Dogan et al., 2021 [61] | • ↓PSV, ↓EDV in TSPCAs | No statistical differences |
| Kocaturk et al., 2016 [58] | • ↓PSV, ↓EDV, ↑RI in OA | - |
| Sekeroglu et al., 2011 [57] | • ↓PSV, ↓EDV, ↑RI (all vessels) | - |
| Martinez et al., 2008 [55] | • ↓EDV, ↑RI (all vessels) | - |
| Martinez et al., 2008 (Eye) [62] | - | •↓PSV, ↓EDV, ↑RI in POAG (vs. PXG) |
| Galassi et al., 2008 [63] | - | •↓PSV, ↓EDV, ↑RI In PXG (vs. POAG) |
| Yuksel et al., 2001 [56] | • ↓PSV, ↓EDV, ↑RI (all vessels) | - |
| Yuksel et al., 2001 [60] | • ↓PSV, ↓EDV, ↑RI (all vessels) | No statistical differences |
POAG: Primary Open Angle Glaucoma, PXG: Pseudoexfoliation Glaucoma, CRA: Central Retinal Artery, TSPCAs: Temporal Short Posterior Ciliary Arteries, PSV: Peak Systolic Velocity, EDV: End Diastolic Velocity, RI: Resistive Index.